A Chinese study analyzing CRLF2 expression in 218 newly diagnosed pediatric ALL patients found that high CRLF2 expression is associated with significantly higher relapse rates and poorer EFS [75]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.